장기칩 시장(2022-2027년) : 세계 산업 동향, 점유율, 규모, 성장, 기회, 예측

The global organ-on-chip market reached a value of US$ 34.52 Million in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 201.13 Million by 2027, exhibiting a CAGR of 31.70% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Organ-on-chip refers to a microfluidic cell culture device utilized in effective drug discovery of precision medicine and a fast-track prospect of tissue engineering. It helps develop a narrow channel for the blood and airflow in organs, such as the lung, gut, liver, and heart. It enables the creation of a specific human model with functional responses at the organ or tissue level to avoid the usage of animal models. Apart from this, it offers several advantages, such as efficient fluid flow, relevant mechanical cues, an organ-level tissue-tissue interface, and separate access to parenchymal and vascular compartments.

Organ-on-chip Market Trends:

There is a currently rise in the demand for organ-on-chips in drug screening to reduce employee healthcare costs; improve employee morale, productivity and performance; and decrease absenteeism, accidents, downtime, turnover, and theft. This, along with the growing demand for lung and kidney-based organ culture devices, represents one of the key factors driving the market. Moreover, there is an increase in the availability of laboratory-engineered functional organs across the globe. This, coupled with the escalating demand for an alternative to animal testing through research activities on organ-on-chip devices for new drug development, is propelling the growth of the market. In addition, the rising adoption of organ-on-chips technology due to advancements in cell biology, microfabrication, and microfluidics is offering lucrative growth opportunities to industry investors. Besides this, the increasing application of organ-on-chips devices in the healthcare industry for real-time imaging, in vitro analysis of biochemical, and genetic and metabolic activities of living cells in a functional tissue are positively influencing the market. Apart from this, key market players are extensively investing in research and development (R&D) activities to develop new solutions and treat pulmonary diseases, which is catalyzing the demand for organ-on-chips technology.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global organ-on-chip market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on offering, type, application and end use.

Breakup by Offering:

• Products
• Services

Breakup by Type:

• Liver
• Heart
• Lung
• Kidney
• Others

Breakup by Application:

• Physiological Model Development
• Drug Discovery
• Toxicology Research

Breakup by End Use:

• Pharmaceutical and Biotechnology Companies
• Academic and Research Institutes
• Cosmetics Industry
• Others

Breakup by Region:

• North America
  • United States
  • Canada

• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others

• Europe
  • Germany
  • France

• United Kingdom
  • Italy
  • Spain
  • Russia
  • Others

• Latin America
  • Brazil
  • Mexico
  • Others

• Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Allevi Inc., Altis Biosystems, AxoSim, BiomimX S.r.l., Elveflow, Emulate Inc., InSphero, MIMETAS, Nortis Inc., TARA Biosystems Inc. and TissUse GmbH.

Key Questions Answered in This Report:

• How has the global organ-on-chip market performed so far and how will it perform in the coming years?

• What has been the impact of COVID-19 on the global organ-on-chip market?

• What are the key regional markets?

• What is the breakup of the market based on the offering?

• What is the breakup of the market based on the type?

• What is the breakup of the market based on the application?

• What is the breakup of the market based on the end use?

• What are the various stages in the value chain of the industry?

• What are the key driving factors and challenges in the industry?

• What is the structure of the global organ-on-chip market and who are the key players?

• What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Organ-on-chip Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Offering

• 6.1 Products
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Services
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast

7 Market Breakup by Type

• 7.1 Liver
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Heart
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Lung
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Kidney
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast
• 7.5 Others
  • 7.5.1 Market Trends
  • 7.5.2 Market Forecast

8 Market Breakup by Application

• 8.1 Physiological Model Development
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Drug Discovery
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Toxicology Research
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast

9 Market Breakup by End Use

• 9.1 Pharmaceutical and Biotechnology Companies
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Academic and Research Institutes
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast
• 9.3 Cosmetics Industry
  • 9.3.1 Market Trends
  • 9.3.2 Market Forecast
• 9.4 Others
  • 9.4.1 Market Trends
  • 9.4.2 Market Forecast

10 Market Breakup by Region

• 10.1 North America
  • 10.1.1 United States
    • 10.1.1.1 Market Trends
    • 10.1.1.2 Market Forecast
  • 10.1.2 Canada
    • 10.1.2.1 Market Trends
    • 10.1.2.2 Market Forecast
• 10.2 Asia-Pacific
  • 10.2.1 China
    • 10.2.1.1 Market Trends
    • 10.2.1.2 Market Forecast
  • 10.2.2 Japan
    • 10.2.2.1 Market Trends
    • 10.2.2.2 Market Forecast
  • 10.2.3 India
    • 10.2.3.1 Market Trends
    • 10.2.3.2 Market Forecast
  • 10.2.4 South Korea
    • 10.2.4.1 Market Trends
    • 10.2.4.2 Market Forecast
  • 10.2.5 Australia
    • 10.2.5.1 Market Trends
    • 10.2.5.2 Market Forecast
  • 10.2.6 Indonesia
    • 10.2.6.1 Market Trends
    • 10.2.6.2 Market Forecast
  • 10.2.7 Others
    • 10.2.7.1 Market Trends
    • 10.2.7.2 Market Forecast
• 10.3 Europe
  • 10.3.1 Germany
    • 10.3.1.1 Market Trends
    • 10.3.1.2 Market Forecast
  • 10.3.2 France
    • 10.3.2.1 Market Trends
    • 10.3.2.2 Market Forecast
  • 10.3.3 United Kingdom
    • 10.3.3.1 Market Trends
    • 10.3.3.2 Market Forecast
  • 10.3.4 Italy
    • 10.3.4.1 Market Trends
    • 10.3.4.2 Market Forecast
  • 10.3.5 Spain
    • 10.3.5.1 Market Trends
    • 10.3.5.2 Market Forecast
  • 10.3.6 Russia
    • 10.3.6.1 Market Trends
    • 10.3.6.2 Market Forecast
  • 10.3.7 Others
    • 10.3.7.1 Market Trends
    • 10.3.7.2 Market Forecast
• 10.4 Latin America
  • 10.4.1 Brazil
    • 10.4.1.1 Market Trends
    • 10.4.1.2 Market Forecast
  • 10.4.2 Mexico
    • 10.4.2.1 Market Trends
    • 10.4.2.2 Market Forecast
  • 10.4.3 Others
    • 10.4.3.1 Market Trends
    • 10.4.3.2 Market Forecast
• 10.5 Middle East and Africa
  • 10.5.1 Market Trends
  • 10.5.2 Market Breakup by Country
  • 10.5.3 Market Forecast

11 SWOT Analysis

• 11.1 Overview
• 11.2 Strengths
• 11.3 Weaknesses
• 11.4 Opportunities
• 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

• 13.1 Overview
• 13.2 Bargaining Power of Buyers
• 13.3 Bargaining Power of Suppliers
• 13.4 Degree of Competition
• 13.5 Threat of New Entrants
• 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

• 15.1 Market Structure
• 15.2 Key Players
• 15.3 Profiles of Key Players
  • 15.3.1 Allevi Inc.
    • 15.3.1.1 Company Overview
    • 15.3.1.2 Product Portfolio
  • 15.3.2 Altis Biosystems
    • 15.3.2.1 Company Overview
    • 15.3.2.2 Product Portfolio
  • 15.3.3 AxoSim
    • 15.3.3.1 Company Overview
    • 15.3.3.2 Product Portfolio
  • 15.3.4 BiomimX S.r.l.
    • 15.3.4.1 Company Overview
    • 15.3.4.2 Product Portfolio
  • 15.3.5 Elveflow
    • 15.3.5.1 Company Overview
    • 15.3.5.2 Product Portfolio
  • 15.3.6 Emulate Inc.
    • 15.3.6.1 Company Overview
    • 15.3.6.2 Product Portfolio
  • 15.3.7 InSphero
    • 15.3.7.1 Company Overview
    • 15.3.7.2 Product Portfolio
  • 15.3.8 MIMETAS
    • 15.3.8.1 Company Overview
    • 15.3.8.2 Product Portfolio
  • 15.3.9 Nortis Inc.
    • 15.3.9.1 Company Overview
    • 15.3.9.2 Product Portfolio
  • 15.3.10 TARA Biosystems Inc.
    • 15.3.10.1 Company Overview
    • 15.3.10.2 Product Portfolio
  • 15.3.11 TissUse GmbH
    • 15.3.11.1 Company Overview
    • 15.3.11.2 Product Portfolio